Pulmonary Arterial Hypertension: A Review of Today's Pharmacotherapy


Date: Jun 21, 2017 12:30 PM - 01:30 PM

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Registration closes on Jun 22, 2017 10:30 PM

Activity Type

Knowledge

Target Audience(s)

Pharmacist

Accreditation(s)

Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Requirements for CE Credit

CPE Monitor: Requirement to Track your CPE
Important new requirement from the Accreditation Council for Pharmacy Education and the National Association of Boards of Pharmacy for all pharmacists and technicians who obtain CPE credit. The CPE Monitor system will securely track all your completed CPE credits in a central system.

https://store.nabp.net/OA_HTML/xxnabpibeGblLogin.jsp 

 

Registration closes on Jun 22, 2017 at 10:30 PM

Registration Closed  

Objectives

  • Describe the pathophysiology and classification of a patient with pulmonary arterial hypertension (PAH).
  • Characterize appropriate pharmacotherapy and treatment for patients with PAH.
  • Distinguish the mechanisms of action, efficacy, and safety of the currently available classes of PAH pharmacotherapy.
  • Outline the role of the pharmacist in providing safe and effective care to patients with PAH.

Speaker(s)/Author(s)

Kyle Startsman, Pharm.D.
Me

Activity Number

0010-0000-17-023-L01-P
Date: 06/21/17
Time: 12:30 PM - 01:30 PM

CE Hours

1.00
Registration Closed